Home » Topics » Regulatory

Regulatory
RSS

Nexium approved for treatment of Zollinger-Ellison syndrome

Oct. 16, 2006

Avastin approved with chemotherapy for first-line treatment of NSCLC

Oct. 13, 2006

Risperdal approved for irritability associated with autistic disorder

Oct. 9, 2006

Brovana approved for COPD

Oct. 9, 2006

Zolinza approved for cutaneous manifestations in CTCL patients

Oct. 9, 2006

Vectibix approved for metastatic colorectal cancer

Sep. 28, 2006

Lamictal approved for new epilepsy indication

Sep. 26, 2006

Idenix receives first approval for novel CHB treatment

Sep. 21, 2006

Lyrica indications broadened in E.U. to include central neuropathic pain

Sep. 19, 2006

Glivec approved in E.U. for additional cancer indications

Sep. 19, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...